Wendell David Associates Inc Becton Dickinson & CO Transaction History

Wendell David Associates Inc

$994 Million
Q2 2025

A detailed history of Wendell David Associates Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Wendell David Associates Inc holds 13,649 shares of BDX stock, worth $2.55 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

13,649

Previous 14,124 3.36%

Holding current value

$2.55 Million

Previous $3.24 Million 27.33%

% of portfolio

0.24%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$165.15 - $226.42 $78,446 - $107,549	-475 Reduced 3.36%	13,649 $2.35 Million
Q4 2024 Jan 17, 2025	SELL	$220.02 - $243.75 $81,627 - $90,431	-371 Reduced 2.56%	14,124 $3.2 Million
Q2 2024 Jul 22, 2024	SELL	$225.07 - $246.17 $139,543 - $152,625	-620 Reduced 4.1%	14,495 $3.39 Million
Q1 2024 Apr 22, 2024	SELL	$233.45 - $247.73 $23,111 - $24,525	-99 Reduced 0.65%	15,115 $3.74 Million
Q4 2023 Jan 22, 2024	SELL	$232.24 - $267.23 $1,161 - $1,336	-5 Reduced 0.03%	15,214 $3.71 Million
Q3 2023 Oct 20, 2023	SELL	$254.9 - $283.59 $57,352 - $63,807	-225 Reduced 1.46%	15,219 $3.94 Million
Q2 2023 Jul 20, 2023	SELL	$238.39 - $265.32 $122,770 - $136,639	-515 Reduced 3.23%	15,444 $4.08 Million
Q1 2023 Apr 19, 2023	SELL	$229.71 - $259.35 $60,873 - $68,727	-265 Reduced 1.63%	15,959 $3.95 Million
Q4 2022 Jan 17, 2023	SELL	$218.29 - $256.91 $39,292 - $46,243	-180 Reduced 1.1%	16,224 $4.13 Million
Q3 2022 Oct 18, 2022	SELL	$51.03 - $264.23 $2,806 - $14,532	-55 Reduced 0.33%	16,404 $3.66 Million
Q2 2022 Jul 14, 2022	SELL	$234.74 - $275.42 $117,370 - $137,710	-500 Reduced 2.95%	16,459 $4.06 Million
Q1 2022 Apr 22, 2022	SELL	$243.64 - $270.48 $146,671 - $162,828	-602 Reduced 3.43%	16,959 $4.51 Million
Q4 2021 Jan 24, 2022	SELL	$230.08 - $250.94 $276,096 - $301,128	-1,200 Reduced 6.4%	17,561 $4.42 Million
Q3 2021 Oct 19, 2021	SELL	$232.72 - $256.47 $1.2 Million - $1.32 Million	-5,165 Reduced 21.59%	18,761 $4.61 Million
Q2 2021 Jul 19, 2021	SELL	$232.65 - $254.58 $1.82 Million - $1.99 Million	-7,808 Reduced 24.6%	23,926 $5.82 Million
Q1 2021 Apr 20, 2021	SELL	$232.09 - $256.88 $39,919 - $44,183	-172 Reduced 0.54%	31,734 $7.72 Million
Q4 2020 Jan 22, 2021	SELL	$221.92 - $245.94 $390,357 - $432,608	-1,759 Reduced 5.23%	31,906 $7.98 Million
Q3 2020 Oct 20, 2020	SELL	$215.77 - $276.76 $599,840 - $769,392	-2,780 Reduced 7.63%	33,665 $7.83 Million
Q1 2020 Apr 16, 2020	SELL	$195.69 - $279.01 $56,358 - $80,354	-288 Reduced 0.78%	36,445 $8.37 Million
Q4 2019 Jan 17, 2020	BUY	$236.45 - $266.82 $146,599 - $165,428	620 Added 1.72%	36,733 $9.99 Million
Q3 2019 Oct 22, 2019	BUY	$230.58 - $256.08 $442,713 - $491,673	1,920 Added 5.62%	36,113 $9.14 Million
Q2 2019 Jul 16, 2019	BUY	$217.4 - $246.08 $202,616 - $229,346	932 Added 2.8%	34,193 $8.62 Million
Q1 2019 Apr 11, 2019	BUY	$206.05 - $248.17 $1.02 Million - $1.23 Million	4,945 Added 17.46%	33,261 $8.31 Million
Q4 2018 Jan 17, 2019	BUY	$204.73 - $257.93 $436,074 - $549,390	2,130 Added 8.13%	28,316 $6.38 Million
Q3 2018 Oct 12, 2018	BUY	$233.07 - $256.0 $512,987 - $563,456	2,201 Added 9.18%	26,186 $6.84 Million
Q2 2018 Jul 16, 2018	BUY	$208.1 - $233.85 $763,727 - $858,229	3,670 Added 18.07%	23,985 $5.75 Million
Q1 2018 Apr 11, 2018	BUY	$205.46 - $240.27 $659,115 - $770,786	3,208 Added 18.75%	20,315 $4.4 Million
Q4 2017 Jan 16, 2018	BUY	$189.0 - $222.64 $42,525 - $50,094	225 Added 1.33%	17,107 $3.66 Million
Q3 2017 Oct 17, 2017	BUY	$186.89 - $198.9 $3.16 Million - $3.36 Million	16,882	16,882 $3.31 Million

Others Institutions Holding BDX

# of Institutions

1,756

Shares Held

259M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $53.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Becton Dickinson & CO Transaction History